DAO and gastrointestinal disease: However, excessive ingestion, the use of DAO inhibitor drugs, alcohol consumption, and cases of concomitant gastrointestinal diseases (for example, gastritis, irritable bowel syndrome, Crohn’s disease, and ulcers) or enzyme-deficiency, may compromise the catabolic capacity of this enzyme.